Universal germline genetic testing catches missed cancer risks in older patients
Universal germline genetic testing of nearly 40,000 patients with solid tumors detected a substantial proportion of inherited gene variants that would have been missed by the standard germline testing approach that excludes those over age 50.
Read original article on The Medical News →Related news
-
Traumatic brain injury can alter the brain's subsequent response to stress, study shows
United Kingdom
-
Q&A: How FDA decision is speeding development of new osteoporosis drugs
United Kingdom
-
Olive oil before carbs blunts early blood sugar rise in mice
United Kingdom
-
Value-aligned messages increased COVID-19 vaccination intentions, study finds
United Kingdom
-
Vaccination protects the immune system from long-term infection damage
United Kingdom
-
FDA-approved epilepsy drug may help reverse osteoarthritis damage
United States
-
Why muscle health should be a bigger part of clinical nutrition
United Kingdom
-
Endless video feeds leave users with ADHD struggling to stop, survey finds
United Kingdom